Question Description
Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer? for CLAT 2024 is part of CLAT preparation. The Question and answers have been prepared according to the CLAT exam syllabus. Information about Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer? covers all topics & solutions for CLAT 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer?.

Solutions for Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer? in English & in Hindi are available as part of our courses for CLAT. Download more important topics, notes, lectures and mock test series for CLAT Exam by signing up for free.

Here you can find the meaning of Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer?, a detailed solution for Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer? has been provided alongside types of Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer? theory, EduRev gives you an ample number of questions to practice Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?a)CoVexb)Corbevaxc)Covdelad)VacdelaCorrect answer is option 'B'. Can you explain this answer? tests, examples and also practice CLAT tests.